FDP
NBIX icon

Financiere des Professionnels’s Neurocrine Biosciences NBIX Stock Holding History

Financiere des Professionnels’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Sell
10,302
-695
-6% -$92.2K 0.08% 175
2025
Q4 		$1.56M Buy
10,997
+2,132
+24% +$309K 0.09% 163
2025
Q3 		$1.24M Buy
8,865
+3,324
+60% +$450K 0.07% 164
2025
Q2 		$696K Buy
+5,541
New +$635K 0.04% 184

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financiere des Professionnels's NBIX Position: Q1 2026 in Review

Financiere des Professionnels reduced its Neurocrine Biosciences (NBIX) stake by 6.3% in Q1 2026, selling an estimated $92.2K and leaving 10,302 shares worth $1.36M. The position accounts for 0.08% of the portfolio, ranked #175.

Financiere des Professionnels first reported a position in NBIX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.56M in Q4 2025. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Financiere des Professionnels held 10,302 shares of Neurocrine Biosciences worth $1.36M as of Q1 2026.
  • Financiere des Professionnels sold 695 Neurocrine Biosciences shares in Q1 2026, an estimated $92.2K.
  • Neurocrine Biosciences made up 0.08% of Financiere des Professionnels's portfolio in Q1 2026, its #175 holding.
  • Financiere des Professionnels first reported a position in Neurocrine Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Financiere des Professionnels's Neurocrine Biosciences position peaked at $1.56M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Financiere des Professionnels's 13F filing for Q1 2026, filed 6 May 2026.